Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemoradiotherapy

  • 62 Accesses

  • 7 Citations

Abstract

The aims of this study were to compare the results of thallium-201 (Tl-201) SPECT, barium swallow and CT in the assessment of the effect of preoperative chemoradiotherapy. This study consisted of 28 patients with advanced esophageal squamous cell carcinoma (AESCC) who underwent the three imaging modalities before and after preoperative chemoradiotherapy. The results were quantified using the bidimensional method for barium swallow and contrast-enhanced CT and the tumor-to-lung ratio for SPECT. The percent decrease in these quantitative values after therapy was defined as %Dba, %Dct and %Dtl respectively. The histological effect of the chemoradiotherapy was determined from the resected surgical specimen of the esophagus: grade 0, 100% viable tumor cells; grade la, 99–67%; grade 1 b, 66–34%; grade 2, 33–1%; grade 3, no viable cells. A statistically significant difference of %Dtl between the subgroups of each grade was evident (p=0.0433), whereas no significant differences were evident for %Dba (p=0.1778) or %Dct (p=0.7377). However, the overlap of %Dtl between these groups was marked. Although thallium-201 SPECT cannot be used to evaluate the therapeutic effect with acceptable accuracy, SPECT may be of additional value to barium swallow and CT in assessing the response of AESCC to preoperative chemoradiotherapy.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.N Engl J Med 1992; 326: 1593–1598.

  2. 2.

    al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.J Clin Oncol 1997; 15: 277–284.

  3. 3.

    Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01).JAMA 1999; 281: 1623–1627.

  4. 4.

    Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.Radiology 1999; 213: 67–72.

  5. 5.

    Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.J Clin Oncol 1993; 11: 1118–1123.

  6. 6.

    Walker SJ, Allen SM, Steel A, Cullen MH, Matthews HR. Assessment of the response to chemotherapy in oesophageal cancer.Eur J Cardio-thorac Surg 1991; 5: 519–522.

  7. 7.

    Jones DR, Parker LA Jr, Detterbeck FC, Egan TM. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy.Cancer 1999; 85: 1026–1032.

  8. 8.

    Okamoto Y, Murakami M, Kuroda M, Mizowaki T, Nakajima T, Kusumi F, et al. Mismatched clinicopathological response after concurrent chemoradiotherapy for thoracic esophageal cancer.Dis Esophagus 2000; 13: 80–86.

  9. 9.

    Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MA. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin’s lymphoma treated with high-dose CHOP chemotherapy.J Clin Oncol 1997; 15: 1631–1637.

  10. 10.

    Front D, Bar-Shalom R, Mor M, Haim N, Epelbaum R, Frenkel A, et al. Aggressive non-Hodgkin lymphoma: early prediction of outcome with67Ga scintigraphy.Radiology 2000; 214: 253–257.

  11. 11.

    Nakahara T, Togawa T, Nagata M, Kikuchi K, Hatano K, Yui N, et al. Detection and chemoradiotherapeutic evaluation of advanced esophageal squamous cell carcinoma using gallium-67 SPECT: a preliminary study.Eur J Nucl Med Mol Imaging 2002; 29: 1072–1077.

  12. 12.

    Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.J Nucl Med 1987; 28: 47–52.

  13. 13.

    Ohtomo K, Terui S, Yokoyama R, Abe H, Terauchi T, Maeda G, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.J Nucl Med 1996; 37: 1444–1448.

  14. 14.

    Arbab AS, Koizumi K, Arai T, Toyama K, Araki T. Application of Tc-99m-tetrofosmin as a tumor imaging agent: comparison with Tl-201.Ann Nucl Med 1996; 10: 271–274.

  15. 15.

    Sun SS, Shih CS, Hsu NY, Teng SC, Kao CH. Detection of esophageal carcinoma using single-photon emission computed tomography with thallium-201: a preliminary report.Anticancer Res 2001; 21: 4109–4112.

  16. 16.

    Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithm.J Comput Assist Tomogr 1995; 19: 615–623.

  17. 17.

    Agha FP, Gennis MA, Orringer MB, Forastiere AA. Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical-pathologic correlation.Am J Clin Oncol 1986; 9: 227–232.

  18. 18.

    Japanese Society for Esophageal Diseases.Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 9th ed. Tokyo; Kanehara, 1999.

  19. 19.

    Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neo-adjuvant) chemoradiotherapy in oesophageal cancer.Br J Surg 2001; 88: 338–356.

  20. 20.

    Samuelsson L, Albertsson M, Hambraeus G, Thorvinger B. Effect of chemotherapy and radiotherapy on squamous cell carcinoma of the esophagus. A preoperative radiologic evaluation.Acta Radiol 1991; 32: 247–250.

  21. 21.

    Liang EY, Chan A, Chung SCS, Metreweil C. Oesophageal tumour volume measurement using spiral CT.Br J Radiol 1996; 69: 344–347.

  22. 22.

    Griffith JF, Chan AC, Chow LT, Leung SF, Lam YH, Liang EY, et al. Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT.Br J Radiol 1999; 72: 678–684.

  23. 23.

    Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells.Brain Res 1989; 500: 30–36.

  24. 24.

    Eary JF. Nuclear medicine in cancer diagnosis.Lancet 1999; 354: 853–857.

  25. 25.

    Lin J, Leung WT, Ho KC, Kumta SM, Metreweli C, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.Eur J Nucl Med 1995; 22: 553–555.

  26. 26.

    Kunisada T, Ozaki T, Kawai A, Sugihara S, Taguchi K, Inoue H. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.Cancer 1999; 86: 949–956.

  27. 27.

    Couper GW, McAteer D, Wallis F, Norton M, Welch A, Nicolson M, et al. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.Br J Surg 1998; 85: 1403–1406.

  28. 28.

    Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.Ann Surg 2001; 233: 300–309.

  29. 29.

    Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.J Clin Oncol 2001; 19: 3058–3065.

  30. 30.

    Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.Cancer 1994; 73: 2680–2686.

  31. 31.

    Dunne B, Reynolds JV, Mulligan E, Kelly A, Griffin M. A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.J Clin Pathol 2001; 54: 841–845.

  32. 32.

    Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with respectable esophageal squamous cell carcinoma.Cancer 2001; 91: 2165–2174.

  33. 33.

    Narita Y, Iida H, Eberl S, Nakamura T. Monte carlo evaluation of accuracy and noise properties of two scatter correction methods for201Tl cardiac SPECT.IEEE Trans Nucl Sci 1997; 44: 2465–2472.

  34. 34.

    Gregorio BT, Fennerty MB, Wilson RA. Noninvasive diagnosis of gastroesophageal inflammation using dipyridamole thallium-201 tomography.Am J Gastroenterology 1998; 93: 1255–1259.

  35. 35.

    Kao CH, Hsieh JF, Tsai SC, Ho YJ, Sun SS. Detection of esophagitis by99mTc-methoxyisobutylisonitrile chest SPECT.J Nucl Med 2000; 41: 1969–1972.

Download references

Author information

Correspondence to Tadaki Nakahara.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nakahara, T., Togawa, T., Nagata, M. et al. Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemoradiotherapy. Ann Nucl Med 17, 583–591 (2003). https://doi.org/10.1007/BF03006672

Download citation

Key words

  • SPECT
  • thallium-201
  • esophageal carcinoma
  • preoperative chemoradiotherapy
  • therapeutic effect